San Francisco - The majority of current treatments for bullous pemphigoid (BP) are not supported by evidence from solid randomized controlled trials, according to Emory University researcher Seaver L. Soon, M.D.
Derm In The News: February 25-March 2
ReV Up Your Vitiligo Treatment Strategies
Pointers With Portela: Dangerous Skin Care Marketing
The Cutaneous Connection: Splish, Splash, AD Management Starts in the Bath
Suicide Risk in Isotretinoin Users: New Data
Johnson & Johnson Innovative Medicine Sponsorship Expands GW Teledermatology Program
2 Commerce Drive Cranbury, NJ 08512